Pfizer and BioNTech to start human trials of COVID-19 vaccine
Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April
Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April
UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents
This strategic partnership aims to expand access to the Tapestri Platform for single-cell multiomics
The combination of the unique technologies aims to bring a novel angle to combat the global pandemic
Free white paper demonstrates the benefits of applied near-infrared spectroscopy
The device enables researchers to analyze their cell cultures remotely, hence minimizing time spent in high-containment labs
The AIHTA have published a comprehensive overview of current research and development activities for evidence-based policy advice
Torx enables collaborative team work and information delivery to accelerate the DMTA workflow for small-molecule discovery
Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation
The project has been launched by Viravaxx and the Medical University of Vienna
Proposed study intended to evaluate the safety and efficacy of opaganib in up to 60 patients hospitalized with positive SARS-CoV-2 infection and pneumonia in the U.S.
Biosero offers free Green Button Go Automation Scheduling Software to research teams to accelerate the treatment and prevention of COVID-19
The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available
The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies
FLIR Systems' infrared thermal cameras are designed to detect elevated body temperatures and mitigate the spread of the virus
The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions